PEDIATRICS Vol. 65 No. 5 May 1980, pp. 1047-1048
This Article
Right arrow Full Text (PDF)
Right arrow This Policy is No Longer Valid.
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Segal, S.
Right arrow Articles by Peter, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Segal, S.
Right arrow Articles by Peter, G.

Prophylaxis and Treatment of Neonatal Gonococcal Infections

Sydney Segal MD, Walter B. Anyan Jr MD, Reba M. Hill MD, Ralph E. Kauffman MD, Howard Mofenson MD, Albert W. Pruitt MD, Henry R. Shinefield MD, Harvey S. Singer MD, Miles M. Weinberger MD, Alfred W. Brann MD, Robert T. Hall MD, Rita G. Harper MD, George A. Little MD, M. Jeffrey Maisels MD, George H. McCracken MD, Ronald Poland MD, Philip Sunshine MD, John A. Whittinghill MD, Edward A. Mortimer Jr MD, Vincent A. Fulginiti MD, Philip A. Brunell MD, Ernesto Calderon MD, James D. Cherry MD, Walton L. Ector MD, Anne A. Gershon MD, Samuel P. Gotoff MD, Walter T. Hughes Jr MD, and Georges Peter MD

The Center for Disease Control (CDC), after consultation with a panel of experts, has revised its recommendations for prevention of gonococcal ophthalmia neonatorum. These recommendations now state, "ophthalmic ointment or drops containing tetracycline or erythromycin or a 1% silver nitrate solution" are effective and acceptable.1-3 This is a change from previous recommendations which highlighted silver nitrate as the primary agent for prophylaxis.4 The American Academy of Pediatrics' committees support these recommendations.

The prevalence of largely asymptomatic genital gonococcal infection in pregnant women and the occurrence of gonococcal ophthalmia in untreated infants (estimated at 28%)5 born to infected women indicate the need for continued prophylaxis for all newborn infants.




This article has been cited by other articles:


Home page
 PediatricsHome page
C. Dani, G. Bertini, M. Pezzati, C. Poggi, P. Guerrini, C. Martano, F. F. Rubaltelli, and and the IntraVentricular Ibuprofen Study Group
Prophylactic Ibuprofen for the Prevention of Intraventricular Hemorrhage Among Preterm Infants: A Multicenter, Randomized Study
Pediatrics, June 1, 2005; 115(6): 1529 - 1535.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
G. A. Bernstein, J. P. Davis, and M. L. Katcher
Prophylaxis of Neonatal Conjunctivitis: An Analytic Review
Clinical Pediatrics, September 1, 1982; 21(9): 545 - 550.
[Abstract] [PDF]